PRTA
NASDAQ · Biotechnology
Prothena Corp Plc
$8.76
+0.18 (+2.10%)
Open$8.54
Previous Close$8.58
Day High$8.85
Day Low$8.04
52W High$11.80
52W Low$7.28
Volume—
Avg Volume557.7K
Market Cap449.19M
P/E Ratio—
EPS$-2.81
SectorBiotechnology
Analyst Ratings
Buy
12 analysts
Price Target
+54.3% upside
Current
$8.76
$8.76
Target
$13.52
$13.52
$9.22
$13.52 avg
$14.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.95M | 17.64M | 162.70M |
| Net Income | -250,849,811 | -400,079,443 | -26,550,677 |
| Profit Margin | -2,520.6% | -2,394.5% | -16.3% |
| EBITDA | -219,660,924 | -369,799,535 | -39,466,979 |
| Free Cash Flow | — | — | -19,760,246 |
| Rev Growth | -43.6% | -43.6% | +13.5% |
| Debt/Equity | — | — | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |